Women’s Health Research Newsletter Winter 2016 Obstetric Studies update Good Clinical Practice (GCP) training PI: Anna David PI: Seni Subair Aim: To collect a detailed database of information about what happens to mothers and babies affected by severe early-onset FGR. This will help us understand more about why severe early onset FGR happens and may help us to develop tests we can use in the future to predict who will be affected and what complications babies are likely to have. Aim: To determine whether delivery in women with pre-eclampsia between 34+0 and 36+6 weeks reduces complications compared with the expectant management. Recruitment: Forty women have been recruited at UCLH. Help us: If you are caring for a woman on labour ward with an EVERREST sticker on their notes, please alert the research team as we need to take cord and placental samples at delivery. For more information: Visit http://everrest-fp7.eu/ Recruitment: Seven women have been recruited at UCLH Help us: The target recruitment has just been increased to two women a month. With help from clinical staff to identify potential participants this should be achievable. So please continue to alert one of the research midwives if you are caring for a woman with preeclampsia. For more information: Visit https://www.npeu.ox.ac.uk/phoenix STOPPIT2 PI: George Attilakos STRIDER PI: Anna David Aim: To see whether giving pregnant women sildenafil (Viagra) improves blood flow to the placenta, which might help overcome some of the problems causing poor growth, potentially delaying delivery so the baby has more time in the womb, which is usually the best place for the baby to develop. Women with severe IUGR before 30 weeks are randomised to take sildenafil or placebo. Recruitment: One woman has been recruited at UCLH. Help us: If you are caring for a woman on labour ward recruited to STRIDER, please alert the research team as we need to take cord and placental samples at delivery. Aim: To determine whether an Arabin cervical pessary prevents preterm birth in women with a twin pregnancy. Recruitment: Fifteen women have been recruited at UCLH (12 to the screening phase and 3 to the randomisation phase). Pessary information for clinical staff: Heavy discharge is normal with the pessary and is not a reason for removal. A speculum can be performed with the pessary in situ. The research team will arrange for the pessary to be removed at 35 – 36 weeks gestation. If admitted with SROM or contracting a doctor should remove the pessary. For more information: Visit https://w3.abdn.ac.uk/hsru/STOPPIT 2/ Everyone involved in the conduct of clinical research must have training to ensure they are best prepared to carry out their duties. This is laid down in the Research Governance Framework for Health and Social Care 2005, covering all research in the NHS in Englan, and in law for those people working on clinical trials. To recruit to research studies you must complete the online GCP training course every two years. We are encouraging all doctors to complete this training so you can assist the research midwives and nurses recruiting to studies that require a doctor to countersign the consent form. When you have completed the online training or if you have a current certificate please bring it, along with your CV, to the research midwives based in Fetal Medicine. We can then update the site files and get your signature on the study delegation logs. This will help to ensure that we are able to recruit all eligible women to our studies. GCP training is free and open to anyone to complete. To get access to the online training please see the link below: http://www.crn.nihr.ac.uk/learningdevelopment/good-clinical-practice/ New Studies Opening Gynaecology Studies update PRISM C-STICH PI: Anna David PI: Davor Jurkovic Aim: To examine the effect of using a monofilament suture material compared with a braided suture material on pregnancy loss rate and neonatal mortality up to one month post-delivery in women presenting with insufficient cervix and treated with cervical cerclage. Aim: To determine whether progesterone is effective to prevent miscarriage in women who present with bleeding in early pregnancy. Recruitment: We aim to recruit 30 women over the next 19 months in the preterm birth clinic. For more information: Visit http://www.birmingham.ac.uk/research/activity/mds/trials /bctu/trials/womens/C-Stich/about.aspx PI: Anna David Aim: To make fetal surgery a safe and accessible option to clinics and surgeons around the world, allowing more babies to benefit from improved longterm outcomes. Recruitment: We aim to recruit 400 women having fetal MRI over the next 5 years. For more information: Visit http://www.gift-surg.ac.uk/ Progesterone is currently used sporadically in threatened miscarriages, by clinicians, but its efficacy is not known due to the lack of robust evidence to support its use. We are recruiting women who are between 4 and 12 weeks pregnant who present with bleeding, and have an intrauterine gestation sac on ultrasound. These women are then randomised to progesterone vaginal pessaries or placebo, which they will take daily until 16 weeks gestation Recruitment: We are recruiting women who are between 4 and 12 weeks pregnant who present with bleeding, and have an intrauterine gestation sac on ultrasound. These women are then randomised to progesterone vaginal pessaries or placebo, which they will take daily until 16 weeks gestation So far, we have randomised 84 women and our aim is to recruit a total of 250 women. Help us: If you are caring for a women taking part in PRISM please ensure they are taking their medication and if there are any problems please inform the research team. For more information: Visit http://www.medscinet.net/prism/ The Baby Biome Study PI: Pat O’Brien Aim: The Baby Biome Study aims to find out how microbes, the immune system and clinical factors during pregnancy, birth, and throughout childhood work together to influence health in later life. To do this we’re collecting samples from mothers and their babies at birth (stool and vaginal swabs from mums, stool from babies, and cord blood). Using these samples, together with clinical information and record linkage, we will be able to find out whether, for example, antibiotics or mode of delivery might affect colonisation of the gut, how microbes and/or infection at birth might affect the immune system, and determine whether a child goes on to develop allergies like asthma and eczema, or autoimmune diseases, amongst other outcomes. Recruitment: We are planning to start recruitment for this study in mid-March. For more information: Visit https://twitter.com/babybiomestudy PRE-EMPT PI: Dimitri Mavrelos Aim: This study is for a large randomised controlled clinical trial in which women undergoing surgery for endometriosis will be randomly allocated to take long acting progesterones, either as three monthly injections or as a contraceptive coil versus the combined oral contraceptive pill. This trial will provide information on which treatment is the most effective in terms of symptom relief. Recruitment: Our recruitment target is 20 and we have currently recruited 14 women to this trial. For more information: Visit http://www.birmingham.ac.uk/research/activity/mds/trials /bctu/trials/womens/pre-empt/index.aspx The Women’s Health Research Team If you would like more information about any of our studies or would like your research featured in the winter newsletter please contact us: Obstetric studies: ext. 76164 or 07903 949 876 All studies: UCLH.researchmidwives@nhs.net Gynaecology studies: ext. 71302